Of the 2,700+ recently funded biopharma companies, we identified 9 of the top teams using our Management Mosaic algorithm. From clinical trials tech to anti-aging drugs, proven founders and teams are innovating in new sectors.
Fueled by the Covid-19 pandemic, biopharma tech funding has been on a tear in recent years, surpassing $52B in 2021 alone.
While companies developing therapies have typically dominated the space, a growing portion of biopharma funding is going to tech companies enabling the drug development process.
But as more companies vie for backing and customers, promising the next great innovations in pharma, enterprises and investors face the challenge of cutting through the noise to identify the most promising startups.
Enter the CB Insights Management Mosaic — an algorithm that demystifies founding and management team quality, offering insight into where an industry is going. With Management Mosaic, it’s possible to see the sectors where proven founders and management teams are focusing their time.
We analyzed the 2,700+ biopharma tech companies funded in the past 2 years and identified 9 of the strongest teams below.
Signaling growth in new sectors, key technology or business innovations in the list include:
- Real-world data
- Anti-aging drugs
- Digital therapeutics
- Digital pharmacy
- Clinical trials tech
This list includes biopharma tech companies that have received funding within the last 24 months (as of 02/1/22).
Management Mosaic scores are as of 5/24/22 — data is dynamic and scores on company profiles may have changed.
You can learn more about Mosaic here and in our whitepaper.
Want the full post? Become a CB Insights customer.
If you’re already a customer, log in here.